Cardiorenal Outcomes With Ertugliflozin by Baseline Metformin Use: Post Hoc Analyses of the VERTIS CV Trial

Francesco Cosentino, Christopher P. Cannon, Robert Frederich, David Z.I. Cherney, Samuel Dagogo-Jack, Richard E. Pratley, James P. Mancuso, Mario Maldonado, Nilo B. Cater, Shuai Wang, Darren K. McGuire

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Pages (from-to)652-654
Number of pages3
Issue number8
StatePublished - Aug 23 2022


  • cardiovascular diseases
  • diabetes mellitus, type 2
  • metformin
  • sodium-glucose transporter 2 inhibitors

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this